Canada markets closed

Mesoblast Limited (LWBA.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
5.300.00 (0.00%)
At close: 3:43PM CEST
Full screen
Previous Close5.30
Open5.35
Bid0.00 x 90000
Ask0.00 x 90000
Day's Range5.30 - 5.35
52 Week Range4.98 - 16.10
Volume30
Avg. Volume56
Market Cap688.868M
Beta (5Y Monthly)2.47
PE Ratio (TTM)N/A
EPS (TTM)-0.69
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Operational Highlights and Financial Results for the Year Ended June 30, 2021

    NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reported operational highlights and financial results for the fourth quarter and full-year ended June 30, 2021 (FY2021). “During this calendar year we made significant progress in both regulatory and clinical outcomes for our lead product candidate, remestemcel-L, after experiencing a disappointing set-back last year” said Silviu It

  • GlobeNewswire

    Mesoblast Corporate Update and Financial Results Webcast

    NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the fourth quarter and full-year ended June 30, 2021. The webcast will begin at 7.00pm EDT, Monday, August 30; 9.00am AEST, Tuesday, August 31, 2021. It can be accessed via: https://webcast.boardroom.media/mesoblast-limited/20210826/NaN61036c41df5665001c97fc67

  • Simply Wall St.

    Loss-Making Mesoblast Limited (ASX:MSB) Expected To Breakeven In The Medium-Term

    With the business potentially at an important milestone, we thought we'd take a closer look at Mesoblast Limited's...